Clinical Trial Update: Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study [Phase 2]

View source ↗

Summary

This phase 2 pilot study evaluates delta-9-tetrahydrocannabinol (Dronabinol) as an orexigenic therapy to improve appetite in advanced cancer patients with chemo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia
• Cancer
• Olfactory Disorders
• Taste Disorders

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

Sponsor: Alberta Health services | Conditions: Cancer, Anorexia | Phase 2 | Status: COMPLETED